Cargando…

Synthesis and validation of click-modified NOD1/2 agonists

NOD1 and NOD2 sense small bacterial peptidoglycan fragments, often called muropeptides, that access the cytosol. These muropeptides include iE-DAP and MDP, the minimal agonists for NOD1 and NOD2, respectively. Here, we synthesized and validated alkyne-modified muropeptides, iE-DAP-Alk and MDP-Alk, f...

Descripción completa

Detalles Bibliográficos
Autores principales: Bharadwaj, Ravi, Anonick, Madison V., Jaiswal, Swati, Mashayekh, Siavash, Brown, Ashley, Wodzanowski, Kimberly A., Okuda, Kendi, Silverman, Neal, Grimes, Catherine L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621468/
https://www.ncbi.nlm.nih.gov/pubmed/37828863
http://dx.doi.org/10.1177/17534259231207198
_version_ 1785130391480303616
author Bharadwaj, Ravi
Anonick, Madison V.
Jaiswal, Swati
Mashayekh, Siavash
Brown, Ashley
Wodzanowski, Kimberly A.
Okuda, Kendi
Silverman, Neal
Grimes, Catherine L.
author_facet Bharadwaj, Ravi
Anonick, Madison V.
Jaiswal, Swati
Mashayekh, Siavash
Brown, Ashley
Wodzanowski, Kimberly A.
Okuda, Kendi
Silverman, Neal
Grimes, Catherine L.
author_sort Bharadwaj, Ravi
collection PubMed
description NOD1 and NOD2 sense small bacterial peptidoglycan fragments, often called muropeptides, that access the cytosol. These muropeptides include iE-DAP and MDP, the minimal agonists for NOD1 and NOD2, respectively. Here, we synthesized and validated alkyne-modified muropeptides, iE-DAP-Alk and MDP-Alk, for use in click-chemistry reactions. While it has long been known that many cell types respond to extracellular exposure to muropeptides, it is unclear how these innate immune activators access their cytosolic innate immune receptors, NOD1 and NOD2. The subcellular trafficking and transport mechanisms by which muropeptides access these cytosolic innate immune receptors are a major gap in our understanding of these critical host responses. The click-chemistry-enabled agonists developed here will be particularly powerful to decipher the underlying cell biology and biochemistry of NOD1 and NOD2 innate immune sensing.
format Online
Article
Text
id pubmed-10621468
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-106214682023-11-03 Synthesis and validation of click-modified NOD1/2 agonists Bharadwaj, Ravi Anonick, Madison V. Jaiswal, Swati Mashayekh, Siavash Brown, Ashley Wodzanowski, Kimberly A. Okuda, Kendi Silverman, Neal Grimes, Catherine L. Innate Immun Original Articles NOD1 and NOD2 sense small bacterial peptidoglycan fragments, often called muropeptides, that access the cytosol. These muropeptides include iE-DAP and MDP, the minimal agonists for NOD1 and NOD2, respectively. Here, we synthesized and validated alkyne-modified muropeptides, iE-DAP-Alk and MDP-Alk, for use in click-chemistry reactions. While it has long been known that many cell types respond to extracellular exposure to muropeptides, it is unclear how these innate immune activators access their cytosolic innate immune receptors, NOD1 and NOD2. The subcellular trafficking and transport mechanisms by which muropeptides access these cytosolic innate immune receptors are a major gap in our understanding of these critical host responses. The click-chemistry-enabled agonists developed here will be particularly powerful to decipher the underlying cell biology and biochemistry of NOD1 and NOD2 innate immune sensing. SAGE Publications 2023-10-13 2023-11 /pmc/articles/PMC10621468/ /pubmed/37828863 http://dx.doi.org/10.1177/17534259231207198 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Articles
Bharadwaj, Ravi
Anonick, Madison V.
Jaiswal, Swati
Mashayekh, Siavash
Brown, Ashley
Wodzanowski, Kimberly A.
Okuda, Kendi
Silverman, Neal
Grimes, Catherine L.
Synthesis and validation of click-modified NOD1/2 agonists
title Synthesis and validation of click-modified NOD1/2 agonists
title_full Synthesis and validation of click-modified NOD1/2 agonists
title_fullStr Synthesis and validation of click-modified NOD1/2 agonists
title_full_unstemmed Synthesis and validation of click-modified NOD1/2 agonists
title_short Synthesis and validation of click-modified NOD1/2 agonists
title_sort synthesis and validation of click-modified nod1/2 agonists
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621468/
https://www.ncbi.nlm.nih.gov/pubmed/37828863
http://dx.doi.org/10.1177/17534259231207198
work_keys_str_mv AT bharadwajravi synthesisandvalidationofclickmodifiednod12agonists
AT anonickmadisonv synthesisandvalidationofclickmodifiednod12agonists
AT jaiswalswati synthesisandvalidationofclickmodifiednod12agonists
AT mashayekhsiavash synthesisandvalidationofclickmodifiednod12agonists
AT brownashley synthesisandvalidationofclickmodifiednod12agonists
AT wodzanowskikimberlya synthesisandvalidationofclickmodifiednod12agonists
AT okudakendi synthesisandvalidationofclickmodifiednod12agonists
AT silvermanneal synthesisandvalidationofclickmodifiednod12agonists
AT grimescatherinel synthesisandvalidationofclickmodifiednod12agonists